Home
- Eating Well (or at Least Not terribly) at Fast Food Resturants
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Heart Care & Heart Disease Articles
Popular Heart Care & Heart Disease Articles
Highly Recommended Heart Care & Heart Disease Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
Aspirin Benefit Blunted in People With Diabetes
An aspirin a day has long been a low-cost preventive therapy to reduce cardiovascular events.
But the Primary Prevention Project (PPP), a randomized trial of nearly 5,000 subjects in Italy-including 1,031 with diabetes-concluded that people with diabetes benefit less than other people with cardiovascular risk factors.
Among people with diabetes, low-dose aspirin (100 mg/day) treatment yielded an insignificant increase in cardiovascular deaths, but it also produced an insignificant reduction in the composite endpoint (total cardiovascular deaths, strokes or heart attacks) and total cardiovascular events.
The results for nondiabetics were more favorable.
The trial was stopped after three and a half years because a consistent benefit overall was found for aspirin therapy compared with the control group. Investigators theorize the anti-platelet effects of aspirin are overwhelmed by aspirin-insensitive mechanisms of platelet activation and thrombus formation common in diabetics.
The researchers note that further large-scale trials addressing the role of aspirin in the primary prevention of cardiovascular disease in people with diabetes are urgently needed.
The PPP study also investigated the role of vitamin E (300 mg/day) in preventing cardiovascular events in people with cardiovascular risk factors. No significant benefit was found with vitamin E in either diabetic or non-diabetic study participants.
-Diabetes Care, December 2003
Categories: Diabetes, Diabetes, Heart Care & Heart Disease, Medications Research
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...